作者:Bhooshan Kafle、Nilkanth G. Aher、Deegendra Khadka、Hwangseo Park、Hyeongjin Cho
DOI:10.1002/asia.201100154
日期:2011.8.1
prepared in a day by using the present protocol. The library compounds thus obtained were examined for their inhibitory activities against PTP1B. Among them, compound C3 was the most potent inhibitor of PTP1B with an IC50 of 2.3 μM. The in vivo effect of C3 was also examined in an obesity‐prone mouse strain. Diet‐induced obese (DIO)/diabetic mice were divided into two groups and each group was fed a
在开发治疗性目标酶的抑制剂中,大量的时间和精力致力于大量化合物的制备。为了开发一种有效的蛋白酪氨酸磷酸酶(PTP)1B抑制剂作为抗肥胖和/或抗糖尿病药,我们使用简化的程序构建了一个异恶唑酮化学库,该程序避免了繁琐的后处理和纯化步骤。10×7异恶唑酮衍生物是通过将两半目标化合物偶联而合成的。当在试管中混合并加热时,前体产生的反应产物为沉淀物。短暂洗涤后,产物纯度足以用于酶促实验。通过制备用于偶联反应的前体,可以使用本方案在一天之内制备10×7库化合物。检查由此获得的文库化合物对PTP1B的抑制活性。其中,复合C3是PTP1B的最有效的抑制剂,其IC 50为2.3μ中号。还对易肥胖的小鼠品系中的C3进行了体内研究。饮食诱导的肥胖(DIO)/糖尿病小鼠分为两组,每组喂养高脂饮食(HFD)或HFD + C3,持续4周。与喂食HFD的对照组相比,在喂食期的四个星期内,C3喂食的小鼠组的体重显着减少。